1-((2-(TRIMETHYLSILYL)ETHOXY)METHYL)-1H-1,2,4-TRIAZOLE, 95.0%, 250mg

(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one, 96%, 250mg

ALISKIREN HEMIFUMARATE, 95%, 50mg

N-(11-BROMOUNDECYL)CARBAMIC ACID TERT-BUTYL ESTER, 95.0%, 250mg

2,4-Dimethylpyrrole>97.0%(GC)1g

(E)-2-(2,6-Dichlorostyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 5g

Sodium phenyl phosphate (dihydrate), 98%, 100g

Urée, min 99,5 %, Ph. Eur., cristal, 5 kg, emballage plastique.

Morpholino(piperidin-4-yl)methanone hydrochloride, 95.0%, 1g

2-Bromo-3,3,3-trifluoropropene, 98.0%, 100g

3,5-DIBROMO-4-METHOXYPYRIDIN-2-AMINE, 95%, 1g

ROTIPHORESE®PAGE Matrix Buffer plus, 250 ml, 1 x 250 ml

5-Methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride, 95.0%, 10g